Anti‐citrullinated peptide antibodies (ACPA) are present in the serum of 80%–90% of RA patients and are more specific for RA than rheumatoid factor (RF), with specificity approaching 90%.2 Here, PRTN3 is linked to rheumatoid arthritis.